Results 241 to 250 of about 212,484 (305)

Evaluating Radiotheranostic Targets for Endometrial Cancer. [PDF]

J Nucl Med
Sebastiano J, McGlone SA, Samuels ZV, Grimaldi C, Stoddard A, Galka S, Colaco E, Zeglis BM.   +7 more
europepmc   +1 more source

Histopathology Images-Based Deep Learning Prediction of Histological Types in Endometrial Cancer. [PDF]

Cancer Med
Li L, Wang P, Geng C, Wang J, Cao L, Gao Y, Chen D, Qiao G, Zhang S, Feng N, Liu M, Li X, Ma Y, Zhang S, Xiao H, Jiang Z, Liu X, Ma W, Qi L.   +18 more
europepmc   +1 more source

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]

, 2019
Cripe, James C, Fuh, Katherine C, Litz, Taylor, Lopez, Heather, Mills, Kathryn A, Mutch, David G, Powell, Matthew A, Sun, Lulu, Thaker, Premal H   +8 more
core   +1 more source

Integrated multi-omics and machine learning highlight PTM-related genes as potential biomarkers in endometrial cancer. [PDF]

Transl Oncol
Zhou X.
europepmc   +1 more source

Expression of Concern: Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

The Role of "Metabolic Instability" as a New Risk Criterion in the Pathogenesis of Endometrial Cancer. [PDF]

Cancers (Basel)
Sukhanova MA, Muraviev SY, Tarabrin EA, Shestakov AL, Berikkhanov ZGM, Tarasova IA, Razumovsky VS, Markov IA, Fabrika AP.   +8 more
europepmc   +1 more source

Extracellular vesicles as biomarkers for endometrial cancer - A systematic review. [PDF]

Transl Oncol
Baxter E, Nair S, West Z, Salomon C, Obermair A.   +4 more
europepmc   +1 more source